Relevant experimental studies on septic myocardial dysfunction indicate that simvastatin may mitigate the inflammatory response in the hearts of rats with sepsis-induced myocardial depression by inhibiting the TLR4-NFκB pathway (Wang et al., 2017). This evidence concerns the gene TLR4 and Sepsis.